Andreas Lehmann

Andreas Lehmann is an accomplished professional with a diverse background in healthcare and business management, currently serving as Executive Director of Key Accounts & Operations at Novartis. With prior roles at Novartis as Executive Director of Large Account Management Operations and Global Director of Commercial Pharma Strategy, Andreas has led high-performing teams across various therapeutic areas. Experience includes advisory and investment roles at multiple early-stage startups, including ClexBio and StanPlus, as well as significant positions in consulting at McKinsey & Company. Educational qualifications include a Bachelor of Law from the University of Berne and an MBA from INSEAD.